You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 6, JUNE 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  CASE REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chronic Myelogenous Leukemia

Possible Association With Reticulum Cell Sarcoma

Eugene P. Libre, MD; William McFarland, MD

Arch Intern Med. 1967;119(6):626-630.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE CONCEPTS of myeloproliferative and lymphoproliferative diseases provide a fluid nosology which interrelates hematologic malignancies on the basis of a common organ system or cell line of origin.1 Thus associated processes are recognized, and within the two broad categories, mergers and transformations from one clinical syndrome to another are relatively common. For example, the patient with chronic myelogenous leukemia (CML) may develop acute leukemia terminally. Giant follicular lymphoma can progress to lymphosarcoma, and lymphosarcoma frequently develops a leukemic phase. Changes that do occur tend to remain within the confines of either one or the other broad category, and transformation from a disease in the myeloproliferative group to one in the lymphoproliferative category would be unusual. Accordingly the coexistence in a patient of CML and reticulum cell sarcoma (RCS) appears, superficially, to be contrary to the usual concepts. The present report concerns a patient with blood and bone marrow findings . . . [Full Text PDF of this Article]


Author Affiliations

Washington, DC

From the Hematology Research Section, Veterans Administration Hospital, Washington, DC. Dr. Libre was formerly a Postdoctoral Fellow in Hematology, Veterans Administration Hospital, Washington, DC; he is presently with the Clinical Hematology Branch, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Md.


Footnotes

Received for publication, June 22, 1966; accepted Nov 11.

Reprint requests to National Institutes of Health, Bethesda, MD 20014 (Dr. Libre).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.